Special Issue on Drug Designing : Edited by Guest Editors

Image

Special Issue on Drug Designing : Edited by Guest Editors

The Drug Designing: Open Access is a peer-reviewed, open-access scholarly journal .journal have been showing tremendous citations and articles focusing the most advanced research trends in the field of drug discovery, medicinal chemistry, Drug Design tools, protein engineering, bioinformatics. As a Managing Editor it is my great pleasure to invite Guest editors and Eminent Authors to participate in the Upcoming special issue of our journal.

The journal focuses on all fields of drug design including drug discovery, drug design by rational approach, target-based design, drug synthesis, drug metabolism, structure-based drug design, molecular modeling, ligand-based interaction, development of the generic drug, in silico chemoinformatics and bioinformatics technologies, receptor agonist/antagonist, protease substrate/inhibitor, peptidomimetic, Quality by design, Design for reliability in drug development, Design for traditional Chinese medicine clinical trials, Bayesian sequential design for multi-regional design, Design and analysis for target clinical trials, Design and analysis for diagnostic procedures, Adaptive design for early clinical development, Design for biosimilar studies, Design for bioassay development and validation, Design for statistical genetics, Design for assessment of drug to drug interaction, Design for bridging studies, Design for stability analysis.

We are considering Research/Review/Case report/Short communication/Commentaries, Image article for possible publication in our journal.

We would like to invite Guest Editors and kindly ask for your suggestions to coin the Special Issue Title. We want to promote our authors globally with our vast range, and thus ensuring quality of unique ideas and their highest standards. Journal aims to disseminate knowledge and promote discussion through the publication of peer-reviewed, high quality research papers on all topics related to Journal. So, in order to maintain the standards of the publication we would feel honoured to invite highly eminent researcher like you from field of immunology based on your contribution in respective field to act as the Guest editors to our upcoming special issue. 

Why to publish with us?

We have Renowned Academicians and Researchers in the Editorial Board and Preliminary quality check report on the article within 48 hours and Article Handling time of less than 30 days, and Fast-track peer-review (Double blinded)

  •  You may suggest your colleagues or outside experts as co-editors and All participating editors can contribute and have importance and rights. 
  • Editorial office will also send invitations to contributors on your behalf.
  • Contributing Editors are requested to contact their colleges and outside experts for submissions. Publication became a valuable tool to profile the expertise of an individual to the scientific community and find partners, in order to initiate bilateral collaborations or other publicly funded projects. Therefore, we are inviting you to be a part of our Special issue.

You can submit your manuscript directly online at: https://www.longdom.org/submissions/drug-designing-open-access.html  

Regards
Sherry Peterson
Journal Manager
Journal Drug Designing: Open Access
Reach us Call or Whatsapp +1-947-333-4405.
Email: 
drugdesign@longdom.org